On behalf of the Scientific Program Planning Committee and PDA, we proudly present you to the Advanced Therapy Medicinal Products Conference and warmly welcome you to Brussels, Belgium!It’s wonderful and exciting that we are able to meet in person after two long years of virtual-only meetings.
Despite the Covid-19 pandemic, the cell-and-gene therapy (CGT) pipeline continues to grow, expand, advance, and diversity in the last two years. The 2022 Conference aims to set a special focus on the specific considerations for the manufacture of ATMPs, to build a bridge between proof of concept and commercial manufacturing. During the opening, we will have a Patient talk, Regulatory Lifecycle, and Regulatory Framework of ATMPs including the attendance of GMP Inspectors. In total, six sessions will focus on Manufacturing with Lessons Learned, Solutions for Products and Hospital, Novel Applications, and the Control and Understanding of Critical Reagents.
Attendees can expect an interactive program and sessions including a panel discussion at the end of the Conference. Don’t miss valuable take-home messages and the important opportunity to engage with industry peers and experts on ATMPs.
We are excited to finally return to a live event, including an exhibition, poster session, and networking opportunities.
We look forward to seeing you soon in Brussels!
Dayue Chen, PhD, Genentech/Roche
SCIENTIFIC PROGRAM PLANNING COMMITTEE
- Dayue Chen, Genentech/Roche, Chair
- Richard Denk, SKAN, Chair
- Christopher Bravery, Advanced Biologicals
- Manuel Carrondo, ibet
- Fabio D’Agostino, Claris Ventures
- Marco Fadda, Comecer
- Irving Ford, Adaptimmune Therapeutics
- Renske ten Ham, Uni Medical Center Utrecht
- Josh Eaton, PDA
- Falk Klar, PDA
- Caroline Lynar, PDA, Junior Manager Programs & Events